| 英文别名 |
CO-1686 HBr;AVL-301 hydrobromide;CNX-419 hydrobromide;Rociletinib hydrobromide;CO-1686 (hydrobromide);CV4XAQ7MUV;2-Propenamide, N-(3-((2-((4-(4-acetyl-1-piperazinyl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)-4-pyrimidinyl)amino)phenyl)-, hydrobromide (1:1);2-Propenamide, N-[3-[[2-[[4-(4-acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-, hydrobromide (1:1);CO 1686 hydrobromide;BCP28816;SB16489;N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;hydrobromide;IPKRDUJIGYXXNT-UHFFFAOYSA-N;CO-1686 hydrobromide?;CS-5247;UNII-CV4XAQ7MUV;HY-15729A;AKOS030526546;CO-1686 hydrobromide;AVL-301 hydrobromide;CNX-419 hydrobromide;AC-35752;F85320;CO-1686 hydrobromide;EX-A1584;CO-1686 HBr salt,Rociletinib HBr salt; AVL-301 HBr salt, CNX-419 HBr salt;1446700-26-0;MS-30890 |